1. Home
  2. NMRA vs LHSW Comparison

NMRA vs LHSW Comparison

Compare NMRA & LHSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • LHSW
  • Stock Information
  • Founded
  • NMRA 2019
  • LHSW 2007
  • Country
  • NMRA United States
  • LHSW China
  • Employees
  • NMRA N/A
  • LHSW N/A
  • Industry
  • NMRA
  • LHSW
  • Sector
  • NMRA
  • LHSW
  • Exchange
  • NMRA Nasdaq
  • LHSW NYSE
  • Market Cap
  • NMRA 121.0M
  • LHSW 101.9M
  • IPO Year
  • NMRA 2023
  • LHSW 2025
  • Fundamental
  • Price
  • NMRA $0.77
  • LHSW $1.47
  • Analyst Decision
  • NMRA Buy
  • LHSW
  • Analyst Count
  • NMRA 8
  • LHSW 0
  • Target Price
  • NMRA $9.29
  • LHSW N/A
  • AVG Volume (30 Days)
  • NMRA 847.9K
  • LHSW 219.1K
  • Earning Date
  • NMRA 08-05-2025
  • LHSW 01-01-0001
  • Dividend Yield
  • NMRA N/A
  • LHSW N/A
  • EPS Growth
  • NMRA N/A
  • LHSW N/A
  • EPS
  • NMRA N/A
  • LHSW 0.05
  • Revenue
  • NMRA N/A
  • LHSW $36,718,017.00
  • Revenue This Year
  • NMRA N/A
  • LHSW N/A
  • Revenue Next Year
  • NMRA N/A
  • LHSW N/A
  • P/E Ratio
  • NMRA N/A
  • LHSW $33.00
  • Revenue Growth
  • NMRA N/A
  • LHSW 24.85
  • 52 Week Low
  • NMRA $0.61
  • LHSW $0.99
  • 52 Week High
  • NMRA $17.19
  • LHSW $8.18
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 45.74
  • LHSW N/A
  • Support Level
  • NMRA $0.81
  • LHSW N/A
  • Resistance Level
  • NMRA $1.34
  • LHSW N/A
  • Average True Range (ATR)
  • NMRA 0.10
  • LHSW 0.00
  • MACD
  • NMRA -0.01
  • LHSW 0.00
  • Stochastic Oscillator
  • NMRA 12.55
  • LHSW 0.00

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

About LHSW LIANHE SOWELL INTERNATIONAL GROUP L

Lianhe Sowell International Group Ltd is a holding company and operates its business through its subsidiary. It is a provider of machine vision products and solutions in China that invent and integrate technologies and solutions that address some of the most critical manufacturing and distribution challenges, such as precision and accuracy required in manufacturing of electronic products. The company categorize machine vision products in four categories based on their application settings: Industrial Machine Vision, Artificial Intelligence (Face Recognition and AI Behavior Analysis), Intelligent Weak Current (Building Intelligence and Intelligent Transportation) and Electronic Customs Clearance.

Share on Social Networks: